A citation-based method for searching scientific literature

Xiang Zhang, Zhen Zhang, Qing Zhang, Quansheng Zhang, Peiqing Sun, Rong Xiang, Guosheng Ren, Shuang Yang. Cell Death Dis 2018
Times Cited: 66







List of co-cited articles
525 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.
Peijing Zhang, Yongkun Wei, Li Wang, Bisrat G Debeb, Yuan Yuan, Jinsong Zhang, Jingsong Yuan, Min Wang, Dahu Chen, Yutong Sun,[...]. Nat Cell Biol 2014
284
39

Pleiotropic Roles for ZEB1 in Cancer.
Julie Caramel, Maud Ligier, Alain Puisieux. Cancer Res 2018
157
19


EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.
Tsukasa Shibue, Robert A Weinberg. Nat Rev Clin Oncol 2017
16

Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity.
Christine L Chaffer, Nemanja D Marjanovic, Tony Lee, George Bell, Celina G Kleer, Ferenc Reinhardt, Ana C D'Alessio, Richard A Young, Robert A Weinberg. Cell 2013
584
15

The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance.
Florian A Siebzehnrubl, Daniel J Silver, Bugra Tugertimur, Loic P Deleyrolle, Dorit Siebzehnrubl, Matthew R Sarkisian, Kelly G Devers, Antony T Yachnis, Marius D Kupper, Daniel Neal,[...]. EMBO Mol Med 2013
252
13

The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer.
Angela M Krebs, Julia Mitschke, María Lasierra Losada, Otto Schmalhofer, Melanie Boerries, Hauke Busch, Martin Boettcher, Dimitrios Mougiakakos, Wilfried Reichardt, Peter Bronsert,[...]. Nat Cell Biol 2017
511
13

miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.
Peijing Zhang, Li Wang, Cristian Rodriguez-Aguayo, Yuan Yuan, Bisrat G Debeb, Dahu Chen, Yutong Sun, M James You, Yongqing Liu, Douglas C Dean,[...]. Nat Commun 2014
127
12

USP51 promotes deubiquitination and stabilization of ZEB1.
Zhicheng Zhou, Peijing Zhang, Xiaoyu Hu, Jongchan Kim, Fan Yao, Zhenna Xiao, Liyong Zeng, Liang Chang, Yutong Sun, Li Ma. Am J Cancer Res 2017
42
19

Molecular mechanisms of epithelial-mesenchymal transition.
Samy Lamouille, Jian Xu, Rik Derynck. Nat Rev Mol Cell Biol 2014
12

A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.
Anne-Pierre Morel, Christophe Ginestier, Roxane M Pommier, Olivier Cabaud, Emmanuelle Ruiz, Julien Wicinski, Mojgan Devouassoux-Shisheboran, Valérie Combaret, Pascal Finetti, Christelle Chassot,[...]. Nat Med 2017
83
12

Epithelial-mesenchymal transitions in development and disease.
Jean Paul Thiery, Hervé Acloque, Ruby Y J Huang, M Angela Nieto. Cell 2009
12

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
Philip A Gregory, Andrew G Bert, Emily L Paterson, Simon C Barry, Anna Tsykin, Gelareh Farshid, Mathew A Vadas, Yeesim Khew-Goodall, Gregory J Goodall. Nat Cell Biol 2008
10

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
Xiaofeng Zheng, Julienne L Carstens, Jiha Kim, Matthew Scheible, Judith Kaye, Hikaru Sugimoto, Chia-Chin Wu, Valerie S LeBleu, Raghu Kalluri. Nature 2015
10

ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat.
Simone Meidhof, Simone Brabletz, Waltraut Lehmann, Bogdan-Tiberius Preca, Kerstin Mock, Manuel Ruh, Julia Schüler, Maria Berthold, Anika Weber, Ulrike Burk,[...]. EMBO Mol Med 2015
142
10

ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types.
Waltraut Lehmann, Dirk Mossmann, Julia Kleemann, Kerstin Mock, Chris Meisinger, Tilman Brummer, Ricarda Herr, Simone Brabletz, Marc P Stemmler, Thomas Brabletz. Nat Commun 2016
186
10

ZEB1-regulated inflammatory phenotype in breast cancer cells.
Akihiro Katsura, Yusuke Tamura, Satoshi Hokari, Mayumi Harada, Masato Morikawa, Tsubasa Sakurai, Kei Takahashi, Anna Mizutani, Jun Nishida, Yuichiro Yokoyama,[...]. Mol Oncol 2017
66
10


DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.
Andreas Eger, Kirsten Aigner, Stefan Sonderegger, Brigitta Dampier, Susanne Oehler, Martin Schreiber, Geert Berx, Amparo Cano, Hartmut Beug, Roland Foisner. Oncogene 2005
583
10

Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications.
Silvia Juliana Serrano-Gomez, Mazvita Maziveyi, Suresh K Alahari. Mol Cancer 2016
350
10

ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance.
Stanislav Drápela, Jan Bouchal, Mohit Kumar Jolly, Zoran Culig, Karel Souček. Front Mol Biosci 2020
55
12

The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.
K Aigner, B Dampier, L Descovich, M Mikula, A Sultan, M Schreiber, W Mikulits, T Brabletz, D Strand, P Obrist,[...]. Oncogene 2007
449
9


The epithelial-mesenchymal transition generates cells with properties of stem cells.
Sendurai A Mani, Wenjun Guo, Mai-Jing Liao, Elinor Ng Eaton, Ayyakkannu Ayyanan, Alicia Y Zhou, Mary Brooks, Ferenc Reinhard, Cheng Cheng Zhang, Michail Shipitsin,[...]. Cell 2008
9


Non-redundant functions of EMT transcription factors.
Marc P Stemmler, Rebecca L Eccles, Simone Brabletz, Thomas Brabletz. Nat Cell Biol 2019
220
9

The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
Karen Hanrahan, Amanda O'Neill, Maria Prencipe, Jane Bugler, Lisa Murphy, Aurelie Fabre, Martin Puhr, Zoran Culig, Keefe Murphy, R William Watson. Mol Oncol 2017
74
7

ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors.
Geoffrey Richard, Stéphane Dalle, Marie-Ambre Monet, Maud Ligier, Amélie Boespflug, Roxane M Pommier, Arnaud de la Fouchardière, Marie Perier-Muzet, Lauriane Depaepe, Romain Barnault,[...]. EMBO Mol Med 2016
75
7

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
Limo Chen, Don L Gibbons, Sangeeta Goswami, Maria Angelica Cortez, Young-Ho Ahn, Lauren A Byers, Xuejun Zhang, Xiaohui Yi, David Dwyer, Wei Lin,[...]. Nat Commun 2014
579
7

Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins.
Antonio A Postigo, Jennifer L Depp, Jennifer J Taylor, Kristen L Kroll. EMBO J 2003
266
7

Identification of the tumour transition states occurring during EMT.
Ievgenia Pastushenko, Audrey Brisebarre, Alejandro Sifrim, Marco Fioramonti, Tatiana Revenco, Soufiane Boumahdi, Alexandra Van Keymeulen, Daniel Brown, Virginie Moers, Sophie Lemaire,[...]. Nature 2018
637
7

ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1.
Yihua Wang, Fangfang Bu, Christophe Royer, Sébastien Serres, James R Larkin, Manuel Sarmiento Soto, Nicola R Sibson, Victoria Salter, Florian Fritzsche, Casmir Turnquist,[...]. Nat Cell Biol 2014
96
7


Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.
Kari R Fischer, Anna Durrans, Sharrell Lee, Jianting Sheng, Fuhai Li, Stephen T C Wong, Hyejin Choi, Tina El Rayes, Seongho Ryu, Juliane Troeger,[...]. Nature 2015
7

Distinct EMT programs control normal mammary stem cells and tumour-initiating cells.
Xin Ye, Wai Leong Tam, Tsukasa Shibue, Yasemin Kaygusuz, Ferenc Reinhardt, Elinor Ng Eaton, Robert A Weinberg. Nature 2015
460
7

EMT: 2016.
M Angela Nieto, Ruby Yun-Ju Huang, Rebecca A Jackson, Jean Paul Thiery. Cell 2016
7

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.
Min Yu, Aditya Bardia, Ben S Wittner, Shannon L Stott, Malgorzata E Smas, David T Ting, Steven J Isakoff, Jordan C Ciciliano, Marissa N Wells, Ajay M Shah,[...]. Science 2013
7

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
Ulrich Wellner, Jörg Schubert, Ulrike C Burk, Otto Schmalhofer, Feng Zhu, Annika Sonntag, Bettina Waldvogel, Corinne Vannier, Douglas Darling, Axel zur Hausen,[...]. Nat Cell Biol 2009
7

The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines.
Octavio Orellana-Serradell, Daniela Herrera, Enrique A Castellón, Héctor R Contreras. Asian J Androl 2019
13
38

ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial-mesenchymal transition and enhancing DNA damage.
Na Song, Wei Jing, Ce Li, Ming Bai, Yu Cheng, Heming Li, Kezuo Hou, Yanrong Li, Kai Wang, Zhi Li,[...]. Cell Cycle 2018
13
38

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
7

The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer.
Simone Spaderna, Otto Schmalhofer, Mandy Wahlbuhl, Arno Dimmler, Katja Bauer, Aneesa Sultan, Falk Hlubek, Andreas Jung, Dennis Strand, Andreas Eger,[...]. Cancer Res 2008
394
7

EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast Cancers.
Mélanie K Prodhomme, Roxane M Pommier, Camille Franchet, Frédérique Fauvet, Valérie Bergoglio, Pierre Brousset, Anne-Pierre Morel, Anne-Cécile Brunac, Mojgan Devouassoux-Shisheboran, Virginie Petrilli,[...]. Cancer Res 2021
15
33

ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells.
Cao Guo, Junli Ma, Ganlu Deng, Yanlin Qu, Ling Yin, Yiyi Li, Ying Han, Changjing Cai, Hong Shen, Shan Zeng. J Cancer 2017
28
14

ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1.
E Sánchez-Tilló, A Lázaro, R Torrent, M Cuatrecasas, E C Vaquero, A Castells, P Engel, A Postigo. Oncogene 2010
313
6

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.
Thiruvengadam Arumugam, Vijaya Ramachandran, Keith F Fournier, Huamin Wang, Lauren Marquis, James L Abbruzzese, Gary E Gallick, Craig D Logsdon, David J McConkey, Woonyoung Choi. Cancer Res 2009
662
6

A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
Bogdan-Tiberius Preca, Karolina Bajdak, Kerstin Mock, Waltraut Lehmann, Vignesh Sundararajan, Peter Bronsert, Alexandra Matzge-Ogi, Véronique Orian-Rousseau, Simone Brabletz, Thomas Brabletz,[...]. Oncotarget 2017
48
8

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.
Jill E Larsen, Vaishnavi Nathan, Jihan K Osborne, Rebecca K Farrow, Dhruba Deb, James P Sullivan, Patrick D Dospoy, Alexander Augustyn, Suzie K Hight, Mitsuo Sato,[...]. J Clin Invest 2016
184
6

Hepatocyte growth factor increases the invasive potential of PC-3 human prostate cancer cells via an ERK/MAPK and Zeb-1 signaling pathway.
Yili Han, Yong Luo, Yongxing Wang, Yatong Chen, Mingchuan Li, Yongguang Jiang. Oncol Lett 2016
31
12

ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.
Yanan Yang, Young-Ho Ahn, Yulong Chen, Xiaochao Tan, Lixia Guo, Don L Gibbons, Christin Ungewiss, David H Peng, Xin Liu, Steven H Lin,[...]. J Clin Invest 2014
90
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.